{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:16Z","timestamp":1793731036314,"version":"4.6.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic inflammation is increasingly recognized as a fundamental driver of pancreatic ductal adenocarcinoma (PDAC) initiation and progression. Although numerous bioinformatics studies have characterized genetic alterations in PDAC, the key inflammatory regulators that bridge tumor cells and the immunosuppressive stroma remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted an integrative multi-omics analysis of TCGA, GEO, and ArrayExpress datasets to define inflammation-associated molecular signatures in PDAC. Differentially expressed genes were analyzed through pathway enrichment, protein\u2013protein interaction modeling, and immune infiltration profiling. Immunotherapeutic relevance was assessed using the IMvigor210 cohort and TIDE algorithm, while drug repurposing candidates were identified via molecular docking. Single-cell RNA sequencing and\n                      <jats:italic>in vitro<\/jats:italic>\n                      functional assays were employed to validate gene expression patterns and mechanistic functions within the PDAC microenvironment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our multi-cohort analysis revealed a robust inflammation-associated gene network in PDAC, with SERPINE1 emerging as a consistent central hub. Elevated\n                      <jats:italic>SERPINE1<\/jats:italic>\n                      expression was tightly linked to a profoundly immunosuppressive tumor microenvironment and predicted diminished responsiveness to immunotherapy across datasets. Structure-based molecular docking further identified Lenvatinib and Dasatinib as previously unappreciated candidate inhibitors of SERPINE1, suggesting actionable therapeutic opportunities. Single-cell transcriptomic profiling resolved nine major cellular compartments and pinpointed fibroblasts as the principal stromal niche orchestrating SERPINE1-driven crosstalk between inflammation and immune evasion, a cellular origin that has not been systematically defined before. Translational analyses demonstrated consistently elevated SERPINE1 in tumor tissues, and functional validation using CRISPR-mediated knockout in PDAC cell lines significantly impaired proliferation and migration while inducing robust apoptosis, thereby establishing SERPINE1 as a previously underappreciated but essential driver of PDAC aggressiveness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This integrative multi-omics and single-cell analysis establishes SERPINE1 as a central orchestrator of inflammation-driven stromal remodeling and immune evasion in PDAC. Its strong prognostic power, combined with newly revealed druggability, positions SERPINE1 as a tractable therapeutic axis for precision immunotherapy and rational drug repurposing. These findings provide a mechanistically grounded and clinically actionable entry point into targeting the inflammatory tumor microenvironment of pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1716878","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:19:56Z","timestamp":1768205996000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrated multi-omics and single-cell analysis identify SERPINE1 as a key mediator of the inflammatory tumor microenvironment in PDAC"],"prefix":"10.3389","volume":"16","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can-ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ccell.2024.08.002","article-title":"Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer","volume":"42","author":"McIntyre","year":"2024","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2(+) macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.108618","article-title":"Integrative single-cell and spatial transcriptomics analysis reveals ECM-remodeling cancer-associated fibroblast-derived POSTN as a key mediator in pancreatic ductal adenocarcinoma progression","volume":"21","author":"Wu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","article-title":"The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer","volume":"39","author":"Freed-Pastor","year":"2021","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01579-x","article-title":"Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC","volume":"24","author":"Baer","year":"2023","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200423095700","article-title":"Chronic pancreatitis and the development of pancreatic cancer","volume":"20","author":"Kandikattu","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25437","article-title":"Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma","volume":"41","author":"Arroyo-Solera","year":"2019","journal-title":"Head Neck"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.19.06166-4","article-title":"Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods","volume":"111","author":"Nie","year":"2020","journal-title":"Minerva Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-06054-x","article-title":"Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-\/PR- breast cancer cells","volume":"186","author":"Tzekaki","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13058-014-0428-4","article-title":"uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies","volume":"16","author":"Duffy","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","article-title":"ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma","volume":"10","author":"Xi","year":"2019","journal-title":"Cell Death Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18579","article-title":"Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer","volume":"28","author":"Ju","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx518","article-title":"Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study","volume":"28","author":"Necchi","year":"2017","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12967-020-02491-w","article-title":"Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment","volume":"18","author":"Wang","year":"2020","journal-title":"J Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.016","article-title":"Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project","volume":"32","author":"Vega","year":"2021","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.patter.2021.100293","article-title":"Interpretable systems biomarkers predict response to immune-checkpoint inhibitors","volume":"2","author":"Lapuente-Santana","year":"2021","journal-title":"Patterns (N Y)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.218","article-title":"Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis","volume":"112","author":"Kirkeg\u00e5rd","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.06.023","article-title":"The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo","volume":"130","author":"Van De Craen","year":"2012","journal-title":"Thromb Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70050","article-title":"Permeable lung vasculature creates chemoresistant endothelial niche by producing SERPINE1 at breast cancer metastatic sites","volume":"116","author":"Hongu","year":"2025","journal-title":"Cancer Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cells13100796","article-title":"SERPINE1: role in cholangiocarcinoma progression and a therapeutic target in the desmoplastic microenvironment","volume":"13","author":"Czekay","year":"2024","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ijo.2021.5239","article-title":"Cancer\u2212associated fibroblast\u2212induced M2\u2212polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor\u22121 pathway","volume":"59","author":"Chen","year":"2021","journal-title":"Int J Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-00512-2","article-title":"PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages","volume":"101","author":"Sakamoto","year":"2021","journal-title":"Lab Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: A phase 2 randomized clinical trial","volume":"5","author":"O\u2019Reilly","year":"2019","journal-title":"JAMA Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202500136","article-title":"SERPINE1 facilitates metastasis in gastric cancer through anoikis resistance and tumor microenvironment remodeling","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.11.659098","article-title":"Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer","author":"Falcomat\u00e0","year":"2025","journal-title":"bioRxiv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365894","article-title":"Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1","volume":"15","author":"Ibrahim","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1716878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:19:57Z","timestamp":1768205997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1716878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2025.1716878"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1716878","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1716878"}}